Sequential, a leader in genomic testing from non-invasive human clinical samples, today announced the successful close of its ...
Founded in 2019, Sequential has developed an extensive B2B platform to conduct research on personal care products through ...
Phase II Study of Afatinib in Patients With Tumors With Human Epidermal Growth Factor Receptor 2–Activating Mutations: Results From the National Cancer Institute–Molecular Analysis for Therapy Choice ...
When clinicians contemplate the use of a new predictive technology in their practice, such as a nomogram, there is always a question of whether the new test is beneficial to their own clinical ...